Dr. Kates is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N. Wolfe Street
Baltimore, MD 21287Phone+1 410-955-6100- Is this information wrong?
Education & Training
- Johns Hopkins UniversityResidency, Urology, 2013 - 2018
- Icahn School of Medicine at Mount SinaiClass of 2012
Certifications & Licensure
- MD State Medical License 2015 - 2024
- American Board of Urology Urology
Publications & Presentations
PubMed
- Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.Liang Dong, Mingxiao Feng, Morgan D Kuczler, Kengo Horie, Chi-Ju Kim, Zehua Ma, Kara Lombardo, Heather Lyons, Sarah R Amend, Max Kates, Trinity J Bivalacqua, David McC...> ;Journal of Extracellular Vesicles. 2024 Feb 1
- Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist.Um, P., Praharaj, M., Lombardo, K., Yoshida, T., Baras, A., Zhao, L., Srikrishna, G., Huang, J., Prasad, P., McConkey, D., Pardoll, D., Bishai, W., Matoso, A., Kates, ...> ;Biorxiv. 2023 Dec 15
- Interruptions in bladder cancer care during the COVID-19 public health emergency.Gore, J., Follmer, K., Reynolds, J., Nash, M., Anderson, C., Catto, J., Chamie, K., Daneshmand, S., Dickstein, R., Garg, T., Gilbert, S., Guzzo, T., Kamat, A., Kates, ...> ;Urologic Oncology. 2023 Dec 11
- Join now to see all
Journal Articles
- Hospitalization and Readmission Costs After Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?Hiten D Patel, Meera R Chappidi, Trinity J Bivalacqua, Gregory A Joice, Phillip M Pierorazio, Max Kates, Nikolai A Sopko, BJU International
Authored Content
- Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm TrialAugust 2021
Press Mentions
- NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder CancerAugust 1st, 2022
- AUA2021 Presentation Highlights Results from a Phase 1/2 Clinical Trial of Intramural/Intravesical NanoDoce® Suspension in High-Risk Nonmuscle Invasive Bladder CancerSeptember 21st, 2021
- Cisplatin Nanoparticles Appear Efficacious for Treating NMIBCNovember 15th, 2017
- Join now to see all
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: